Sympathetic activity in children undergoing balloon valvuloplasty of pulmonary stenosis

Pediatric Research

Volumn 39, Issue 5, 1996, Pages 774-778

  Galal, Omar ^a   Dzimiri, Nduna ^a   Moorji, Azadali ^a   Bakr, Soliman ^a   Almotrefi, Abdulrahman A ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CYANOPINDOLOL I 125; CYCLIC AMP; DOPAMINE; NORADRENALIN; TRITIUM; YOHIMBINE;

ADOLESCENT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUCTUS ARTERIOSUS OBLITERATION; HUMAN; INFANT; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; RECEPTOR BINDING; RECEPTOR DENSITY; SYMPATHETIC TONE; TRANSLUMINAL VALVULOPLASTY;

EID: 0030005758     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199605000-00005     Document Type: Article

References (40)

1. Lock JE, Bass JL, Amplatz K, Furhman BP, Castaneda-Zuniga W 1983 Balloon dilatation angioplasty of aortic coarctations in infants and children. Circulation 68:109-116
2. Lababidi AZ, Daskalopoulos DA, Stoeckle H 1984 Transluminal balloon coarctation angioplasty: experience with 27 patients. Am J Cardiol 54:1288-1291
3. Khan JS, White RI, Mitchell SE, Gardner TJ 1982 Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary valve stenosis. N Eng J Med 307:540-542
4. Rey C, Marache P, Francart C, Dupuis C 1988 Percutaneous transluminal balloon valvuloplasty of congenital pulmonary valve stenosis, with special report on infants and neonates. J Am Coll Cardiol 11:815-820
5. Radtke W, Keane JF, Fellows KE, Lang P, Lock JE 1986 Percutaneous balloon valvotomy of congenital pulmonary stenosis using oversized balloons. J Am Coll Cardiol 8:909-915
6. Qureshi SA, Kirk CR, Lamb RK, Arnold R, Wilkinson JL 1988 Balloon dilatation of the pulmonary valve in the first year of life in patients with tetralogy of Fallot: a preliminary study. Br Heart J 60:232-235
7. Parsons JM, Ladusans EJ, Qureshi SA 1989 Growth of the pulmonary artery after neonatal balloon dilatation of the right ventricular outflow tract in an infant with tetralogy of Fallot and atrioventricular septal defect. Br Heart J 62:65-68
8. Sreeram N, Saleem M, Jackson M, Peart I, McKay R, Arnold R, Walsh K 1991 Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol 18:159-165
9. Sommer RJ, Golinko RJ 1991 Is there a choice of palliation for tetralogy of Fallot. J Am Coll Cardiol 18:166-167
10. Choy M, Rocchini AP, Beekman RH, Rosenthal A, Dick M, Crowley D, Behrendt D, Snider AR 1987 Paradoxical hypertension after repair of coarctation of the aorta in children: balloon angioplasty versus surgical repair. Circulation 75:1186-1191
11. Sealy WC 1976 Coarctation of the aorta and hypertension. Ann Thorac Surg 21:15
12. Goodall M, Sealy WC 1969 Increased sympathetic nerve activity following resection of coarctation of the thoracic aorta. Circulation 39:345
13. Benedict CR, Grahame-Smith DG, Fisher M 1987 Changes in plasma catecholamine and dopamine beta hydroxylase after corrective surgery for coarctation of the aorta. Circulation 57:598-602
14. Rocchini AP, Rosenthal A, Barger AC, Castaneda AR, Nadas AS 1976 Pathogenesis of paradoxical hypertension after coarctation resection. Circulation 54:382-387
15. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN 1982 Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone level and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49:1659-1666
16. Anton AH, Sayre DF 1962 A study of factors affecting the aluminum oxide trihydroxindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138:360-375
17. Bristow MR, Hershberger RE, Port JD, Sandoval A, Rasmussen R, Cates AE, Feldman AM 1990 β-Adrenergic pathways in non-failing and failing human ventricular myocardium. Circulation 82:I12-I25
18. Homcy CJ, Vatner SF, Vatner DE 1991 β-Adrenergic receptor regulation in the heart in pathophysiological states: abnormal adrenergic responses in cardiac disease. Annu Rev Physiol 53:137-159
19. Brodde O-E, Michel MC 1992 Adrenergic receptors and their signal transduction mechanism in hypertension. J Hyperten 10:S133-S145
20. Colucci WS 1990 In vivo studies of myocardial β-adrenergic receptor pharmacology in patients with congestive heart failure. Circulation 82:44-51
21. Böhm M, Diet F, Feiler G, Kemker B, Erdmann E 1988 α-Adrenoceptor and α-adrenoceptor-mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol 12:357-364
22. Bristow MR, Minok W, Ramussen R, Hershberger RE, Hoffman B 1988 Alpha-1-adrenergic receptors in non-failing and failing human heart. J Pharmacol Exp Ther 247:1039-1045
23. Lee HR 1989 α-Adrenergic receptors in heart failure. Heart Failure 5:62-79
24. Dzimiri N, Galal O, Moorji A, Bakr S, Abbag F, Fadley F, Almotrefi AA 1995 Regulation of sympathetic activity in children with various congenital heart diseases. Pediatr Res 37:1-6
25. Dzimiri N, Prabhakar G, Moorji A, Bakr S, Halees Z, Duran C 1994 α-Adrenoceptor activity in patients with rheumatic heart valvular disease. Can J Physiol Pharmacol 72(Suppl 1):119
26. McGrath LB, Chen C, Gu J, Bianchi J, Levett JM 1991 Determination of infundibular innervation and amine receptor content in cyanotic and acyanotic myocardium: relation to clinical events in tetralogy of Fallot. Pediatr Cardiol 12:155-160
27. Hertel C, Nunnally MH, Wong SK, Murphy EA, Ross EM, Perkins JP 1990 A truncation in the avian β-adrenergic receptor causes agonist-induced internationalization and GTP-sensitive agonist binding characteristic of mammalian receptors. J Biol Chem 265:17988-17994
28. Von Zastrow M, Kobilka BK 1994 Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. J Biol Chem 269:18448-18452
29. Brown L, Deighton NM, Bals S, Sohlmann W, Zerkowski H-R, Michel MC, Brodde O-E 1992 Spare receptors for β-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J Cardiovasc Pharmacol 19:222-232
30. Lewis AB, Takahashi M 1988 Plasma catecholamine responses to balloon angioplasty in children with coarctation of the aorta. Am J Cardiol 62:649-650
31. Brodde O-E 1990 Physiology and pharmacology of cardiovascular catecholamine receptors; implications for treatment of chronic heart failure. Am Heart J 120:1565-1572
32. Eschenhagen T 1993 G protein and the heart. Cell Biol Int 17:723-749
33. iα-2 in human end-stage heart failure. Circ Res 70:688-696
34. Tsien RW 1989 Cyclic AMP and contractile activity in the heart. Adv Cyclic Nucleotide Res 65:1417-1425
35. s and stimulate adenylyl cyclase in human pituitary tumors. Nature 340:692-696
36. Weinstein LS, Shenker A 1993 G protein mutations in human heart. Clin Biochem 26:333-338
37. Spiegel AL, Shenker A, Weinstein LS 1992 Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocr Rev 13:536-565
38. m cAMP phosphodiesterase in heart is mediated by a pertussis toxin-sensitive G-protein. J Biol Chem 267:15496-15501
39. Thapar M, Rao S 1990 Use of propranolol for severe dynamic infundibular obstruction prior to balloon pulmonary valvuloplasty. (A brief communication). Cathet Cardiovasc Diagn 19:240-241
40. Fontes VF, Esteves CA, Sousa JE, Silva MVD, Bembom MCB 1988 Regression of infundibular hypertrophy after pulmonary valvuloplasty for pulmonary stenosis. Am J Cardiol 62:977-982